Summary of Consolidated Financial Statements for the Second Quarter Fiscal 2025 (JPGAAP)10/29TDnetPDF(511KB)
(Update of the Previous Announcement) Notice Concerning the Acquisition of a Newly Established Company that will succeed JSR's IVD business10/1TDnetPDF(139KB)
Summary of Consolidated Financial Statements for the First Quarter Fiscal 2025 (JPGAAP)7/29TDnetPDF(722KB)
Efforts to Realize Management Conscious of the Cost of Capital and Stock Price (Update)4/28TDnetPDF(400KB)
Notice Concerning the Acquisition of a Newly Established Company that will succeed JSR's in vitro diagnostic pharmaceutical business4/22TDnetPDF(146KB)